Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Community & Systems Health Science Division, College of Nursing, University of Arizona, Tucson, AZ 85721, USA.
Ann Hepatol. 2023 Sep-Oct;28(5):101120. doi: 10.1016/j.aohep.2023.101120. Epub 2023 Jun 2.
Various studies have identified single-nucleotide polymorphisms (SNPs) associated with nonalcoholic fatty liver disease (NAFLD) and related traits, including ones located in or near the LYPLAL1, GCKR, PPP1R3B, TM6SF2, MBOAT7, and PNPLA3 genes. However, these SNPs were identified primarily in populations of European ancestry. This study examined the associations of these previously identified SNPs with hepatic steatosis in a sample of Mexican-origin adults living in Southern Arizona.
A total of 307 Mexican-origin adults between the ages of 18 and 64 with a body mass index (BMI) of 25 kg/m2 or higher were genotyped at the following SNPs: rs12137855 (LYPLAL1), rs1260326 (GCKR), rs4240624 (PPP1R3B), rs58542926 (TM6SF2), rs641738 (MBOAT7), and rs738409 (PNPLA3). Hepatic steatosis was assessed by transient elastography (FibroScan®) with controlled attenuation parameter. Regression models examined the association between each of the six SNPs and hepatic steatosis. BMI was examined as a potential modifier of the genetic associations.
Participants were, on average, 45 years old and mostly female (63%) with an overall mean hepatic steatosis of 288.1 dB/m. Models showed no associations between LYPLAL1, GCKR, PPP1R3B, TM6SF2, or MBOAT7 and hepatic steatosis. Only PNPLA3 was statistically significantly associated with hepatic steatosis in both unadjusted and adjusted models (p<0.01). There was no effect modification observed with BMI.
SNPs associated with NAFLD in populations of European descent did not strongly contribute to hepatic steatosis in individuals of Mexican-origin, except for rs738409 (PNPLA3). Further efforts are necessary to explore additional SNPs that may be associated with NAFLD in this high-risk population.
多项研究已确定与非酒精性脂肪性肝病(NAFLD)和相关特征相关的单核苷酸多态性(SNP),包括位于 LYPLAL1、GCKR、PPP1R3B、TM6SF2、MBOAT7 和 PNPLA3 基因内或附近的 SNP。然而,这些 SNP 主要是在欧洲血统人群中发现的。本研究在亚利桑那州南部的墨西哥裔成年人样本中,检测了先前鉴定的这些 SNP 与肝脂肪变性的关联。
共对 307 名年龄在 18 至 64 岁之间、体重指数(BMI)为 25kg/m2 或更高的墨西哥裔成年人进行了以下 SNP 的基因分型:rs12137855(LYPLAL1)、rs1260326(GCKR)、rs4240624(PPP1R3B)、rs58542926(TM6SF2)、rs641738(MBOAT7)和 rs738409(PNPLA3)。肝脂肪变性通过瞬时弹性成像(FibroScan®)和受控衰减参数进行评估。回归模型检测了六个 SNP 中的每一个与肝脂肪变性之间的关联。BMI 被检测为遗传关联的潜在修饰因子。
参与者的平均年龄为 45 岁,主要为女性(63%),总体平均肝脂肪变性为 288.1dB/m。模型显示 LYPLAL1、GCKR、PPP1R3B、TM6SF2 或 MBOAT7 与肝脂肪变性之间没有关联。只有 PNPLA3 在未调整和调整后的模型中均与肝脂肪变性呈统计学显著相关(p<0.01)。未观察到 BMI 的修饰作用。
与欧洲血统人群的 NAFLD 相关的 SNP 并不能强烈导致墨西哥裔个体的肝脂肪变性,除了 rs738409(PNPLA3)。需要进一步努力探索可能与该高危人群的 NAFLD 相关的其他 SNP。